Navigation Links
Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
Date:4/16/2008

spimycin is also being studied in HER2-positive metastatic breast cancer in combination with Herceptin(R) (trastuzumab). Epothilones inhibit cell division with a mechanism of action similar to taxanes, one of the most successful classes of anti-tumor agents. KOS-1584 is in Phase 1 clinical trials in patients with solid tumors. Kosan's motilin agonist compound, KOS-2187, licensed to Pfizer for development in gastroesophagel reflux disease, is in a Phase 1 trial. For additional information on Kosan Biosciences, please visit the company's website at http://www.kosan.com.

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 (the "Act"). Such forward-looking statements include but are not limited to statements regarding the further development and potential safety, efficacy, regulatory status, commercial potential and other characteristics of Kosan's product candidates; the continuation of current clinical trials; the initiation of additional clinical trials and the timing thereof and the use of Kosan's financial resources. Words such as "will," "expect," "believe," "may," "intend," "plan," "potential" and similar expressions are intended to identify forward-looking statements. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements are based upon Kosan's current expectations. Forward-looking statements involve risks and uncertainties. Kosan's actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the uncertain progress and results of Kosan's preclinical and clinical testing, including the risks that studies and trials may not demonst
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
2. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
3. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Kosan Presents Phase 1 Data Showing Antitumor Activity and Safety Profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting
6. Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
7. Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer
8. Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer
9. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
10. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 The medical magnetic resonance imaging ... 4%, with world market revenues for 2013 at ... other types of medical imaging have led to ... medical conditions in children and adults, each imaging ... Medical Imaging Markets , analyzes the current ...
(Date:11/26/2014)... , November 25, 2014 ... Market by Power Source (Electric, Battery, Pneumatic), by ... Blade, Burr, Cart), by Application (Orthopedic, ENT, Oral, ... by MarketsandMarkets, the global Powered Surgical Instruments Market is ... Billion in 2014 and is expected to grow ...
(Date:11/26/2014)... , Nov. 25, 2014  goBalto, Inc., the leading ... recognized as a winner of Red Herring,s Top ... Top 100 North America award in 2013, marking its ... landscape. Red Herring,s Top 100 Global list ... new companies and entrepreneurs. Red Herring editors were among ...
Breaking Medicine Technology:Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3
... Codexis, Inc. (Nasdaq: CDXS ) today announced the ... Technology Leadership Forum, to be held in Vail, CO on ... Financial Officer, will appear on a panel titled "Crude Alternatives: ... 8 at 12:30 p.m. ET. A webcast is not being ...
... 14, 2011 Neuralstem, Inc. (NYSE Amex: ... notice of allowance for U.S. Patent Applications 12/939,897 ...  The patents cover three new compounds and include ... and the growth of new neurons, both in-vitro ...
Cached Medicine Technology:Neuralstem Announces Notice of Allowance for Two Additional Neurogenic Compound Patents 2Neuralstem Announces Notice of Allowance for Two Additional Neurogenic Compound Patents 3
(Date:11/26/2014)... CA (PRWEB) November 26, 2014 With ... orthopedic surgeon Dr. Steven Meier has enhanced the ... offer current and prospective patients an online destination for ... really excited to present the new and improved version ... features make it easier than ever for current and ...
(Date:11/26/2014)... 2014 Sonru, the video interviewing specialist, ... Operating Officer and Chief Marketing Officer, in addition to ... , Jeff Jones has been appointed as Chief Operating ... the role of Chief Marketing Officer. , Mr Jones ... 25-year career includes senior roles with The Walt Disney ...
(Date:11/26/2014)... 2014 Medical suction and vacuum products ... 5. This score represents steady growth in the price ... 2014 as a result of swelling demand for healthcare ... are largely considered nondiscretionary. IBISWorld market research analyst, Anna ... some degree of flexibility, given the low level of ...
(Date:11/26/2014)... 2014 News Facts , Lexmark’s ... at RSNA 2014 in Chicago. The company will ... diagnostic images, photos, videos and documents found throughout ... will learn more about these innovative medical content ... partner initiatives – that enable more informed clinical ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Vultures have developed highly ... ingest when eating dead animals, researchers report. The ... on the faces and in the guts of 50 ... On average, the faces of the vultures had more ... in their guts, the study found. The findings ...
Breaking Medicine News(10 mins):Health News:Los Angeles Orthopedic Surgeon Dr. Steven Meier Announces Relaunch Of Practice Website 2Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3
... is lot of controversies over the usage of Generic drugs in ... done a survey to find out that usage of generic drugs ... be more in the future. Though it is well known that ... industries, who would not accept this fact but the reality is ...
... Brompton and Harefield NHS Trust have found Cryosurgery effective ... team has so far operated 16 patients using this ... surgical removal of tumor mass is not possible. It ... diseased lung is not possible due to severe breathing ...
... from persistence of REM activity, including typical paralysis associated// ... become aware or as they are falling asleep. ... surroundings, but are unable to move. Hallucinations, such as ... chest, and hearing footsteps or odd sounds commonly accompany ...
... is considered to be a unifying link between diabetes ... sufficient evidence on increased production of oxidants and decreased ... contributes to oxidative stress. An increase in oxidative stress ... in diabetic patients. ,A new study, which ...
... Cardiovascular diseases have now become common place owing to ... style. Time and over again, scientists have been working ... surgical intervention. The results of a recent research have ... treatment of cardiovascular diseases. ,The leeches have ...
... present in the central nervous system, including// that of ... yet. Altered prionic proteins, pathogens, infectants, i.e. prions, are ... encephalopathy (BSE or mad cow disease). In order to ... the importance of this investigation for the location of ...
Cached Medicine News:Health News:Generic Drugs Usage In US Can Save $20 Billion – Express Script Surve 2Health News:Cryosurgery – Freeze Therapy For Lung Cance 2Health News:Isolated Sleep Paralysis In Patients With Anxiety Disorders 2Health News:Protein Carbonyl Level Causes Oxidative Protein Damage In Diabetics 2Health News:Leeches Provide Clues Regarding The Prevention Of Heart Disease 2Health News:The 'Mad Cow' Disease And Protein 2
... is effective against gram positive and gram ... interfering with bacterial protein synthesis by binding ... suggested working concentration of 50 mg/L is ... thereby making a gentler alternative to penicillin ...
... new approach to practice management, built to address ... healthcare market. OPIE was created by practicing O&P ... in this field, so it thinks the way ... than anything else available. If you believe there ...
... new hand-held Slit Lamp HSL150 with an ... For Human and Veterinary medicine for the ... an ergonomic, compact,design, the new HEINE HSL ... slit lamp is not available,or practical to ...
... used for endophotocoagulation indications, ... uncompromised laser treatment of ... handpieces are compatible with ... (532 nm), OcuLight infrared ...
Medicine Products: